Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
Be
CAS Number:
Molecular Weight:
9.01
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12141501
MDL number:
InChI
1S/Be
SMILES string
[Be]
InChI key
ATBAMAFKBVZNFJ-UHFFFAOYSA-N
assay
≥99.7%
form
wire
autoignition temp.
1198 °F
manufacturer/tradename
Goodfellow 957-976-92
resistivity
4.46 μΩ-cm, 20°C
bp
2970 °C (lit.)
mp
1278 °C (lit.)
density
1.85 g/mL at 25 °C (lit.)
Looking for similar products? Visit Product Comparison Guide
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
signalword
Danger
Hazard Classifications
Acute Tox. 3 Oral - Carc. 1B - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 1
Storage Class
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Massimo Amicosante et al.
Clinical immunology (Orlando, Fla.), 121(2), 134-143 (2006-05-16)
Chronic beryllium disease (CBD) is a granulomatous lung disorder caused by beryllium exposure in the workplace and is characterized by the accumulation of beryllium-specific CD4(+) T cells. Depending on genetic susceptibility and the nature of the exposure, CBD occurs in
Paolo Boffetta et al.
Critical reviews in toxicology, 42(2), 107-118 (2012-01-27)
There is controversy on whether occupational exposure to beryllium causes lung cancer. We conducted a systematic review of epidemiologic studies on cancer among workers exposed to beryllium, including a study of seven U.S. production plants which has been recently updated
Erin Shay et al.
Critical reviews in toxicology, 43(3), 220-243 (2013-03-01)
The exposure-response patterns with beryllium sensitization (BeS), chronic beryllium disease (CBD) and lung cancer are influenced by a number of biological and physicochemical factors. Recent studies have suggested dermal exposure as a pathway for BeS. In light of the current
Kathleen Kreiss et al.
Annual review of public health, 28, 259-277 (2006-11-11)
Beryllium exposure can cause a granulomatous lung disease in workers who develop a lymphocyte-mediated sensitization to the metal. Workers in diverse industries are at risk because beryllium's properties are critical to nuclear, aerospace, telecommunications, electronic, metal alloy, biomedical, and semiconductor
Linus H Santo Tomas
Current opinion in pulmonary medicine, 15(2), 165-169 (2009-06-18)
This review aims to present the clinician with a synthesis of recent studies that have enhanced our understanding of the epidemiology and pathogenesis of beryllium hypersensitivity (BeH) and chronic beryllium disease (CBD). Lower occupational limit levels to beryllium exposure and
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service